biopharmatips

                             Medical and biopharmaceutical drugs impact every individual and the regulatory authorities such as the Food and Drug Administration (FDA) enforce strict guidelines carefully. The governing standard for human consumption that ensures production of drugs of the highest quality is known as Current Good Manufacturing Practice ( CGMp Manufacturing ). Current Good Manufacturing Practice is an integral aspect of the pharmaceutical industry. By following this practice, each batch of drugs for humans will meet the set standards. Often people are unaware of CGMPs, or how the drug authority assures that drug production fulfil these elementary objectives. Of late, FDA announced several regulatory actions against drug companies based on the limited number of CGMPs.  What Do CGMPs Have to Offer? CGMPs assure pro...

Biopharmaceutical Contract Manufacturing Organizations (CMOs) provide biopharma companies the choice to improve process efficiencies and prioritize their capacities. These companies offer services to biotechnology and pharma companies from product development to the final production of the product. Certain CMOs offer extraordinary end-to-end biologics capabilities with the world’s most advanced production facilities. The services offered by leading biologics provide the following expertise: Validation cGMP manufacturing Analytical characterization Fermentation biotechnology Process optimization Cell line development. CMOs can be hired to carry out small work as well as the large production work such as the manufacturing of the liquid and solid dosage forms. CMOs have played a major role in the biopharma industry’s growth for a long time, but it is only in the past couple of decades that they have become a vital element in the operations of bio/pharmaceutical ...

A few years back, US drug authority Food and Drug Administration (FDA) published a guidance work that introduced the concept of Process Analytical Technology (PAT) and redefined quality assurance and pharmaceutical manufacturing for the future. In the same guidance a concept known as "real-time release," was introduced, which is defined as "the ability to assess and certify the suitable quality of final and/or in-process product based on process data". PAT enables the introduction of innovative technologies into manufacturing in the pharmaceutical industry. In today's competitive environment, firms must strive to enhance pharmaceutical quality control while lowering production costs. PAT’s goal is to improve understanding and regulate the manufacturing process, which is as per the FDA's existing drug quality system. CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities, and ...